PHILADELPHIA — June 6, 2006 — The
Philadelphia Stock Exchange (PHLX) announced today that it will
begin trading one new option beginning Wednesday, June 7. Citadel
Derivatives Group, LLC will be the specialist in this option.
Adventrx Pharmaceuticals, Inc. (option/stock symbol:
ANX) will trade on the January expiration cycle
with initial expiration months of June, July, October and January.
Position and exercise limits have been set at 75,000 contracts.
The Philadelphia Stock Exchange was founded in 1790. The PHLX trades
2,000 stocks, more than 2,200 equity options, 19 sectors index options
and currency options and futures. For more information about the
PHLX and its products, visit www.phlx.com.
###
